TSHA Competitors & Alternatives
Compare Taysha Gene Therapies Inc with similar stocks in the same industry
Biotechnology
TSHA
Main Stock$4.67
Tradestie Score
59
Market Cap
$867.49M
Revenue Growth
1.7%
Analyst Upside
+178.7%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNKD
Mannkind Corporation
|
$3.76
|
$1.65B | - | 50 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$41.17
|
$1.63B | - | 46 | Compare |
|
BHVN
Biohaven Ltd.
|
$12.74
|
$1.57B | - | 50 | Compare |
|
VCEL
Vericel Corporation
|
$40.15
|
$1.56B | 83.6 | 57 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.23
|
$1.55B | - | 63 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$39.60
|
$1.55B | 12.7 | 60 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.07
|
$1.55B | - | 54 | Compare |
|
NVAX
Novavax Inc
|
$10.38
|
$1.54B | - | 41 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$15.80
|
$1.50B | 7.1 | 49 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$28.30
|
$1.50B | - | 40 | Compare |
More TSHA Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
230 stocks in this industry